NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.6400
-0.0400 (-5.88%)
At close: Feb 9, 2026
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 58.04 million as of February 9, 2026. Its market cap has increased by 25.51% in one year.
Market Cap
58.04M
Enterprise Value
56.78M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.64
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 58.04M, an increase of 73.33%. That is a compound annual growth rate of 16.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 61.66M | 3.03% |
| Dec 31, 2025 | 59.85M | 36.16% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ME Therapeutics Holdings | 75.12M |
| Medicenna Therapeutics | 68.40M |
| Sharp Therapeutics | 66.17M |
| Sernova Biotherapeutics | 52.56M |
| MedMira | 45.61M |
| BriaCell Therapeutics | 35.41M |
| Defence Therapeutics | 35.00M |
| Microbix Biosystems | 33.31M |